Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy
The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Abstract
The highly immunosuppressive tumor microenvironment (TME) in solid tumors often dampens the efficacy of immunotherapy. In this study, bacterial outer membrane vesicles (OMVs) are demonstrated as powerful immunostimulants for TME reprogramming. To overcome the obstacles of antibody‐dependent clearance and high toxicity induced by OMVs upon intravenous injection (a classic clinically relevant delivery mode), calcium phosphate (CaP) shells are employed to cover the surface of OMVs, which enables potent OMV‐based TME reprograming without side effects. Meanwhile, the pH‐sensitive CaP shells facilitate the neutralization of acidic TME, leading to highly beneficial M2‐to‐M1 polarization of macrophages for improved antitumor effect. Moreover, the outer shells can be integrated with functional components like folic acid or photosensitizer agents, which facilitates the use of the OMV‐based platform in combination therapies for a synergic therapeutic effect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“OMVs with calcium phosphate (CaP) shells promoted cytotoxic T cell infiltration and M2 to M1 macrophage polarization, effectively improving the immunosuppressive TME [123] (Fig. 5H).”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · doi:10.1186/s13045-022-01273-9 · cites this paper as [123]
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,409
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051
Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,299
Molecular tectonics in biomineralization and biomimetic materials chemistry
Mann, S. (1993) · Nature · doi:10.1038/365499a0 · Cited by 1,165
Rodell, C. B., Arlauckas, S. P., Cuccarese, M. F., Garris, C. S., Li, R., Ahmed, M. S., Kohler, R. H., Pittet, M. J., & Weissleder, R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0236-8 · Cited by 1,099
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079
Research works printed but not linked: 1
- Schwechheimer C., 2015, Nat. Rev. Immunol., 13, 605
Cited by
Items 101–200 of 333
Zhao, R., Hou, Y., Li, B., Pan, Z., Qiu, J., Wang, Q., Qi, Y., Han, Z. W., Zhao, H., Liu, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63081-2 · Cited by 49
“Bacterialouter membrane vesicles (OMVs) are highly immunogenic nanovesicles that effectively stimulate macrophages to adopt an M1-like phenotype and have become a commonly used delivery vehicle for tumour immunotherapy 19,20 .”
Zhu, C., Ji, Z., Ma, J., Ding, Z., Shen, J., & Wang, Q. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070940 · Cited by 45
“CT26 and 4T1 tumors OMV ICG (1) Surface is functionalized with a calcium phosphate shell to respond to the acidic environment of the tumor (2) Combination of photothermal therapy and immunotherapy [68]”
BackgroundOh, B. S., Choi, W. J., Kim, J., Ryu, S. W., Yu, S. Y., Lee, J., Park, S., Kang, S. W., Lee, J., Jung, W. Y., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.736343 · Cited by 44
“In addition, bacterial OMVs have been demonstrated to be potent anti-cancer agents by effecting a significant reduction in tumor growth in vivo (Qing et al., 2020).”
BackgroundLiang, J., Cheng, K., Li, Y., Xu, J., Chen, Y., Ma, N., Feng, Q., Zhu, F., Ma, X., Zhang, T., et al. (2021) · Fundamental Research · doi:10.1016/j.fmre.2021.11.032 · Cited by 44
“Although immune checkpoint inhibitors have achieved remarkable clinical benefits in cancer treatment, they still encounter the challenge of a limited number of infiltrating T cells in the tumor microenvironment [ 17 , 42 , 43 ].”
BackgroundThe emerging role of bacterial extracellular vesicles in human cancers
Liang, A., Korani, L., Yeung, C. L. S., Tey, S. K., & Yam, J. W. P. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12521 · Cited by 45
“Various technologies are being used to assemble or load chemotherapy drugs, photosensitizers, biotoxins and other therapeutic agents into targeted BEVs (Figure 2) (Feng et al., 2022; Li, Wu, et al., 2023; Qing et al., 2020; Ren et al., 2023, Zanella et al., 2021).”
Loo, Y. S., Bose, R. J., McCarthy, J. R., Azmi, I. D. M., & Madheswaran, T. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.017 · Cited by 43
RBD-Modified Bacterial Vesicles Elicited Potential Protective Immunity against SARS-CoV-2
Yang, Z., Hua, L., Yang, M., Liu, S.-Q., Shen, J., Li, W., Long, Q., Bai, H., Yang, X., Ren, Z., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c00680 · Cited by 43
Chen, Q., Liu, C., Liu, C., Zhong, D., Hua, S., He, J., Wang, K., & Zhou, M. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101311 · Cited by 41
Immunomodulatory metal-based biomaterials for cancer immunotherapy
Yuan, K., Zhang, C., Pan, X., Hu, B., Zhang, J., & Yang, G. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.008 · Cited by 41
Niu, M., Li, Q., Huang, Q., Qin, Y., Meng, D., Liang, J., & Zhang, X. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202413255 · Cited by 40
Bacterial extracellular vesicles for gut microbiome–host communication and drug development
Qian, D., Xu, P., Wang, X., Du, C., Zhao, X., & Xu, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.008 · Cited by 41
Zhang, J., Li, Z., Liu, L., Li, L., Zhang, L., Wang, Y., & Zhao, J. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s353330 · Cited by 41
Shi, E., Shan, T., Wang, H., Mao, L., Liang, Y., Cao, M., Wu, Q., Li, C., Wang, Y., & Wang, Y. (2023) · Small · doi:10.1002/smll.202304014 · Cited by 40
Lin, Y.-H., Chen, C.-W., Chen, M.-Y., Xu, L., Tian, X., Cheung, S.-H., Wu, Y.-C., Siriwon, N., Wu, S., & Mou, Y. (2025) · ACS Nano · doi:10.1021/acsnano.5c02541 · Cited by 37
Engineered bacteria for augmented in situ tumor vaccination
Shen, X., Zhu, C., Liu, X., Zheng, H., Wu, Q., Xie, J., Huang, H., Liao, Z., Shi, J., Nan, K., et al. (2023) · Biomaterials Science · doi:10.1039/d2bm01593e · Cited by 38
Self-citationSelf‐Oxygenated Biomimetic Nanozyme for Tumor Catalytic Immunotherapy
Zhang, B., Yuan, Y., Qi, X., Wang, S., Feng, Y., Yan, X., Fan, T., Jiang, B., & Yue, Y. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202411103 · Cited by 38
Self-citationEngineering nanoplatforms of bacterial outer membrane vesicles to overcome cancer therapy resistance
Chai, Q., Li, D., Zhang, M., Gu, Y., Li, A., Wu, X., Liu, X., & Liu, J. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101277 · Cited by 36
Pei, Z., Li, L., Yang, N., Sun, S., Jiang, N., & Cheng, L. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215969 · Cited by 37
Xiang, S., Yao, Q., Khan, A., & Wang, D. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101049 · Cited by 36
Lipid-based nanoparticles for cancer immunotherapy
Fan, S., Han, H., Yan, Z., Lu, Y., He, B., & Zhang, Q. (2023) · Medical Review · doi:10.1515/mr-2023-0020 · Cited by 33
“In contrast, OMVs are nonspecifically detected and phagocytized by macrophages owing to the high immunogenicity [36, 227].”
BackgroundFu, C., Tang, L., Cao, Y., Yin, Y., Liu, H., Feng, J., Gao, J., Li, J., & Wang, W. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.156420 · Cited by 33
Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy
Thomas, C. J., Delgado, K., Sawant, K., Roy, J., Gupta, U., Song, C. S., Poojary, R., de Figueiredo, P., & Song, J. J. (2024) · Cancers · doi:10.3390/cancers16223810 · Cited by 35
Du, X., Dong, Z., Yan, Y., Gong, Y., Yuan, M., Ma, C., Xu, L., Qu, Y., Qu, M., Pan, P., et al. (2025) · Exploration · doi:10.1002/exp.20250127 · Cited by 33
“In our experiments, attenuated gram-negative bacteria of Escherichia coli ( E. coli )-derived OMVs obtained by vacuum filtration and ultracentrifugation were employed [34].”
Self-citationYu, Y., Xie, B., Liu, X., Ye, J., Zhong, Z., & Zhang, X. (2023) · ACS Nano · doi:10.1021/acsnano.3c02126 · Cited by 33
Development of Drug-Resistant Klebsiella pneumoniae Vaccine via Novel Vesicle Production Technology
Li, W., Hu, Y., Zhang, Q., Hua, L., Yang, Z., Ren, Z., Zheng, X. W., Huang, W., & Ma, Y. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c06701 · Cited by 33
Transformable vesicles for cancer immunotherapy
Wang, S., Hu, X., Wei, W., & Ma, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113905 · Cited by 32
Self-citationZeng, Y., Zou, F., Xia, N., & Li, S. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2238807 · Cited by 31
“Biomineralized OMVs (OMV@CaP) can effectively promote reprogramming of the tumor environment, making them a potential candidate for adjuvant delivery research platforms for tumor vaccines [98].”
BackgroundWu, N., Han, Z., Lv, W., Huang, Y., Zhu, J., Deng, J., & Xue, Q. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123198 · Cited by 31
RETRACTED ARTICLE: Engineered outer membrane vesicles enhance solid tumour CAR-T cell therapy
Li, X., Li, X., Shi, J., Li, Y., Zhang, H., Chen, T., Pang, H., Zhang, S., Luo, S., Liu, F., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01575-6 · Cited by 31
RetractedLi, Y., Zhang, H., Shi, C., Zhou, Q., Li, J., Lu, B., Lu, H., Jin, T., Zhu, Y., Zuo, T., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.031 · Cited by 31
“To address this challenge, research indicates that surface modifications of EcN-OMVs, such as the application of polymer coatings ( i . e ., chitosan, polyethylene glycol, or glycosylation), can markedly improve their stability within the gastrointestinal tract 48,49 .”
Living therapeutics: Precision diagnosis and therapy with engineered bacteria
Xie, R., Fan, D., Cheng, X., Yin, Y., Li, H., Wegner, S. V., Chen, F., & Zeng, W. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123342 · Cited by 31
Next-generation probiotics and engineered BEVs for precision therapeutics in osteoporosis
Wei, J., Ding, W., Song, K., Zhang, Y., Luo, Q., & Qi, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1581971 · Cited by 31
Zhao, G., Wang, S., Nie, G., & Li, N. (2024) · Med · doi:10.1016/j.medj.2024.03.012 · Cited by 30
Self-citationChen, Z., Wu, Y., Yao, Z., Su, J., Wang, Z., Xia, H., & Liu, S. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c12990 · Cited by 29
Ren, C., Li, Y., Cong, Z., Li, Z., Xie, L., & Wu, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1129771 · Cited by 29
“5-conjugated antiCD11b (45-0112-80) and FITC-conjugated anti-F4/80 (11-480182) were employed to stain macrophage cells.”
BackgroundMethodInfluentialHarnessing Bacterial Membrane Components for Tumor Vaccines: Strategies and Perspectives
Bai, Z., Wang, X., Liang, T., Xu, G., Cai, J., Xu, W., Yang, K., Hu, L. T., & Pei, P. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401615 · Cited by 28
Xue, K., Wang, L., & Liu, J. (2022) · Materials Advances · doi:10.1039/d2ma00420h · Cited by 28
Advancement of Engineered Bacteria for Orally Delivered Therapeutics
Guo, P., Wang, S., Yue, H., Zhang, X., Ma, G., Li, X., & Wei, W. (2023) · Small · doi:10.1002/smll.202302702 · Cited by 30
Self-citationRecent advances in biomedical applications of bacterial outer membrane vesicles
Chen, H., Zhou, M., Zeng, Y., Lv, Z., Wang, P., & Han, L. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00683a · Cited by 26
Marzoog, T. R., Jabir, M. S., IBRAHEEM, S. A., Jawad, S. F., Hamzah, S. S., Sulaiman, G. M., Mohammed, H. A., & Khan, R. A. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119486 · Cited by 26
Chen, S., He, Y., Huang, X., Shen, Y., Zou, Q., Yang, G., Fu, L., Liu, Q., & Luo, D. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02612-3 · Cited by 27
“Immunotherapy has advanced in treating cancer, yet solid tumors respond at a rate below 30%, largely due to the immunosuppressive nature of the TME [9, 10].”
BackgroundBacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
Yan, S., Gan, Y., Xu, H., & Piao, H. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1526612 · Cited by 24
Microrobotic Swarms for Cancer Therapy
Xie, L., Liu, J., Yang, Z., Chen, H., Wang, Y., Du, X., Fu, Y., Song, P., & Yu, J. (2025) · Research · doi:10.34133/research.0686 · Cited by 30
“Besides, bacterial OMVs are naturally produced by the membrane of Gram-negative bacteria during growth and have recently become immunotherapeutic agents for a variety of biomedical applications [ 140 , 141 ].”
Wang, Y., Xiao, S., Yu, W., Han, B. R., & Guo, G. F. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01766-3 · Cited by 26
“Their therapeutic mechanisms are multifaceted: OMVs are efficiently internalized by macrophages in the TME, reprogramming immunosuppressive M2 macrophages into antitumor M1 phenotypes via TLR4/NF-κB signaling [232].”
Bacterial extracellular vesicles: Emerging nanoplatforms for biomedical applications
Gurunathan, S., & Kim, J. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106308 · Cited by 24
Li, X., Xu, S., Su, Z., Shao, Z., & Huang, X. (2025) · ACS Omega · doi:10.1021/acsomega.4c10865 · Cited by 23
Li, Y., Liu, X., Cui, Z., Zheng, Y., Jiang, H., Zhang, Y., Li, Z., Zhu, S., Chu, P. K.-H., & Wu, S. (2023) · Research · doi:10.34133/research.0096 · Cited by 23
“The outer membrane vesicles inherited partial membrane protein and can be used as antigens in consequence [39,40].”
BackgroundYang, X., Shi, G., Lin, Z., Qiu, Y., Liu, F., Hu, K., Guo, J. J., Peng, H., & He, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113702 · Cited by 22
Engineered Bacterial Extracellular Vesicles: Developments, Challenges, and Opportunities
Li, Q., Chen, X., Xie, J., & Nie, S. (2025) · Engineering · doi:10.1016/j.eng.2025.06.042 · Cited by 23
Shape-directed drug release and transport of erythrocyte-like nanodisks augment chemotherapy
Wang, N., Li, J., Wang, J., Nie, D., Jiang, X., Zhuo, Y., & Yu, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.005 · Cited by 22
Self-citationPeritumoral scaffold neutralizes tumor pH for chemotherapy sensitization and metastasis inhibition
Yan, Y., Li, J., Yi, X., Liu, C., Zhou, Z., Huang, Y., & Li, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.006 · Cited by 22
Bacterial outer membrane vesicles as drug delivery carrier for photodynamic anticancer therapy
Jiang, Y., Zhou, Z., Liu, C., Wang, L., & Li, C. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1284292 · Cited by 23
The potential role of gut microbiota outer membrane vesicles in colorectal cancer
Meng, R., Zeng, M., Ji, Y., Huang, X., & Xu, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1270158 · Cited by 23
“After E. coli W3110 msbB mutant-derived OMVs injection into the tail vein of CRC CT26 mice, OMVs specifically targeted and accumulated in tumor tissue and subsequently induced (Qing et al., 2020).”
MethodEngineered bacterial extracellular vesicles for gastrointestinal diseases
Nie, X., Li, Q., He, Y., Xu, Y., Qiao, S., Wang, X., Meng, F., Xie, J., & Nie, S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113972 · Cited by 23
Jiang, S., Fu, W., Wang, S., Zhu, G., Wang, J., & Ma, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311222 · Cited by 21
“created a biomineralized OMV with an active-targeting ligand to improve antitumor therapy efficacy by targeting the TME in solid tumors [25].”
BackgroundSelf-citationBacteria-Based Nanoprobes for Cancer Therapy
Lu, Y., Mei, N., Ying, Y., Wang, D., Li, X., Zhao, Y., Zhu, Y., Shen, S., & Yin, B. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s438164 · Cited by 22
“178 In terms of good biodegradability and biocompatibility, organic PTAs bring negligible health risk and are favorable in recent bacterial-mediated phototherapy studies.”
BackgroundRecent advances in therapeutic engineered extracellular vesicles
Yao, C., Zhang, H., & Wang, C. (2024) · Nanoscale · doi:10.1039/d3nr05470e · Cited by 23
Liu, J., Li, Q., Tu, H., Feng, J., Fan, X., Mi, Z., Han, H., Ma, X., Liang, Q., Zhang, Z., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.158683 · Cited by 21
Li, P., Yao, Y., Chen, X., Song, C. Q., Wu, M., Huang, J., Wang, D., Li, X., Luo, B., Yang, X., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.145738 · Cited by 20
Harnessing Bacterial Extracellular Vesicle Immune Effects for Cancer Therapy
Karaman, İ., Pathak, A., Bayık, D., & Watson, D. C. (2024) · Pathogens and Immunity · doi:10.20411/pai.v9i1.657 · Cited by 20
“When paired with a photosensitizer, these encapsulated bEVs elicited photothermal immunogenic cell death in CT26 solid tumor mice and 4T1 tumor mice [173].”
BackgroundWu, C. F., Gao, M., Xiao, W., Huang, X., Yang, X., Wu, Z., Yu, X., Mo, B., Du, Z., Shang, Z., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03408-5 · Cited by 20
“Specifically, M1 macrophages are typically stimulated by proinflammatory factors and exhibit strong antitumor activity, secreting proinflammatory cytokines such as tumor necrosis factor-α and IL-12, which enhance antigen presentation and T cell activation [66].”
Jin, L., Zhang, Z., Tan, X., Wang, Z., Tang, B., Wang, Z., Li, M., Mi, T., Shen, L., Long, C., et al. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022127 · Cited by 26
Biogenetic Vesicle‐Based Cancer Vaccines with Tunable Surface Potential and Immune Potency
Qin, H., Li, H., Zhu, J., Qin, Y., Li, N., Shi, J. Y., Nie, G., & Zhao, R. (2023) · Small · doi:10.1002/smll.202303225 · Cited by 19
Jiang, Y., Zhu, Y., Shao, Y., Yang, K., Zhu, L., Liu, Y., Zhang, P., Zhang, X., & Zhou, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c07717 · Cited by 19
Self-citationSalmonella enterica and outer membrane vesicles are current and future options for cancer treatment
Jorge, G. P., Gontijo, M. T. P., & Brocchi, M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1293351 · Cited by 20
Liang, R., Li, P., Yang, N., Xiao, X., Gong, J., Zhang, X., Bai, Y., Chen, Y., Xie, Z., & Liao, Q. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s457338 · Cited by 19
“57 This holds positive implications for clinical translation, further enriching the therapeutic landscape for colon cancer.”
BackgroundLi, Y., Zhu, T., Chen, J., Liu, K., Wei, C., Fang, Q., Huang, X., & Shan, H. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202401355 · Cited by 20
Guan, M., Xie, X., Zhou, D., Cheng, K., Zhang, B., Xu, X., Li, Y., Zhou, Y., Wei, P., Chen, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202505000 · Cited by 20
Engineering Bacteria and Their Derivatives for Cancer Immunotherapy
Tang, Y., Chen, Y., & Rao, L. (2024) · BME Frontiers · doi:10.34133/bmef.0047 · Cited by 18
“OMVs are encapsulated with pH-sensitive calcium phosphate nanoshells for delivery to tumor tissues [17].”
BackgroundChen, C., Zhang, W., Lu, S., Wang, J., Tan, Y., Zhao, S., Ouyang, Y., Xu, L., Zhou, B., Yin, X., et al. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113157 · Cited by 18
Self-citationLi, S., Li, X., Meng, J., Bao, W., Wang, S., Ye, P., Gao, X., & Wei, W. (2023) · Nano Research · doi:10.1007/s12274-023-6225-6 · Cited by 18
Self-citationDuan, Y., Zhang, W., Ouyang, Y., Yang, Q., Zhang, Q., Zhao, S., Chen, C., Xu, T., Zhang, Q., Ran, H., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c01451 · Cited by 18
Gao, P., Duan, Z., Xu, G., Gong, Q., Wang, J., Luo, K., & Chen, J. (2024) · Advanced Materials · doi:10.1002/adma.202405075 · Cited by 18
Self-citationJiang, G., Xiang, Z., & Fang, Q. (2023) · Nanoscale Horizons · doi:10.1039/d3nh00061c · Cited by 18
Jiang, Y., Wang, L., Yang, B., Ma, G., Chen, Z., Ma, J., Chang, X., Fang, L., & Wang, Z. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08702-z · Cited by 18
Self-citationCheng, L., Peng, D., Liu, Z., Tang, J., Zhang, P., Li, M., Li, J., Le, Z., & Liu, J. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123725 · Cited by 19
Ge, Y., Sun, F., Zhao, B., Kong, F., Li, Z., & Kong, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1103446 · Cited by 17
“During laser ablation, a large amount of cancer antigens is released for immune priming after their accumulation in tumours (121).”
BackgroundExtracellular Membrane Vesicles of Escherichia coli Induce Apoptosis of CT26 Colon Carcinoma Cells
Jiang, Y., Ma, J., Long, Y., Dan, Y., Fang, L., & Wang, Z. (2024) · Microorganisms · doi:10.3390/microorganisms12071446 · Cited by 17
“A previous study about the treatment of colorectal tumors with E. coli -OMVs has shown that transcriptomic analysis reveals an increase in apoptosis-related genes, providing crucial clues to explore the anti-tumor mechanisms of E. coli -OMVs [20].”
BackgroundBiomimetic mineralization: construction and biomedical applications of biohybrid materials
Chen, T., Wang, Y., Wang, K., Dai, M., Duan, Y., Mao, C., & Wan, M. (2024) · Materials Chemistry Frontiers · doi:10.1039/d4qm00506f · Cited by 19
Engineering of calcium overload for state-of-the-art tumor therapy
Liu, X., Hu, H., Chen, J., Li, Y., Cheng, Y., Wei, H., & Yu, C. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.157747 · Cited by 17
Lu, S., Wang, J., Wang, X., Yang, W., Jin, M., Xu, L., Yang, H., Ge, X., Shang, C., Chao, Y., et al. (2022) · Small Methods · doi:10.1002/smtd.202101551 · Cited by 17
Self-citationZhang, F., Li, Q., Dai, H., Li, W., Chen, X., Wu, H., Lu, S., Luo, R., Li, F., Lu, G., et al. (2025) · Advanced Science · doi:10.1002/advs.202417712 · Cited by 16
Self-citationGut microbiome and gastric cancer: microbial interactions and therapeutic potential
El-Ghannam, M., Hassanien, M. H., Ameen, Y. A., Turky, E. A., ELattar, G. M., Ray, A. A. E., & Eltalkawy, M. D. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00729-w · Cited by 16
Akbariqomi, M., Zarandi, P. K., Abedi, A., Moghaddam, M. M., & Fooladi, A. A. I. (2025) · Microbial Cell Factories · doi:10.1186/s12934-025-02838-2 · Cited by 17
A long-term self-driven metronomic photodynamic system for cancer therapy
Wang, W., Ye, B., Li, Z., Li, Z., Huang, Q., Zhou, J., Hu, M., Jiang, J., Wang, W., Mao, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63868-3 · Cited by 16
Zhao, L., Xin, J., Hu, M., Xue, C., & Dong, N. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.028 · Cited by 19
“4A) [92].”
Ma, S., Xu, W., Fei, Y., Li, D., Jia, X., Wang, J., & Wang, E. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301413 · Cited by 16
Self-citationNovel immunotherapies for breast cancer: Focus on 2023 findings
Lan, H., Chen, M., Yao, S.-Y., Chen, J.-X., & Jin, K. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111549 · Cited by 18
Yin, X., Ke, Y., Liang, Y., Zhang, S., Chen, Z., Yu, L., Jiang, M., Liu, Q., & Gu, X. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401373 · Cited by 16
Application of bacterial extracellular vesicles in gastrointestinal diseases
Wang, Y., Zu, M., Li, B., Reis, R. L., Kundu, S. C., & Xiao, B. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.05.022 · Cited by 15
Shen, M., Guo, L., Zhang, H., Zheng, B., Liu, X., Gu, J., Yang, T., Sun, C., & Yi, X. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02565-7 · Cited by 15
“Moreover, OM plays a key role in many aspects of innate and adaptive immunity [40].”
BackgroundLiu, K., Du, S., Yang, J., Li, J., Wang, S., Zhang, Z., Luo, W., Chen, C., Yang, J., & Han, X. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.008 · Cited by 15
Self-citationCellular transformers for targeted therapy
Chen, C., Zhang, Y., Chen, Z., Yang, H., & Gu, Z. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114032 · Cited by 15
Recent advances in biological membrane-based nanomaterials for cancer therapy
Shen, M., Wu, X., Zhu, M., & Yi, X. (2022) · Biomaterials Science · doi:10.1039/d2bm01044e · Cited by 15
Li, L., Zhen, M., Wang, H., Sun, Z., Cao, X., Li, J., Liu, S., Zhao, Z., Zhou, C., Wang, C., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101702 · Cited by 15
Advances of Bacterial Biomaterials for Disease Therapy
Lin, Z., Fu, L., Wei, W., & Zheng, D. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00022 · Cited by 14
Self-citationLi, M., Wang, Y., Liu, H., Huang, X., Peng, H., Yang, Y., Hu, Z., Dou, J., Xiao, C., Chen, J., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s455158 · Cited by 14
Tumor microenvironment: A playground for cells from multiple diverse origins
Bharadwaj, D., & Mandal, M. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189158 · Cited by 15
Bacterial outer membrane vesicles in the fight against cancer
Meng, Y., Kong, C., Ma, Y., Sun, J., & Zhang, G. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003234 · Cited by 14
“[24] This synergistic effect disintegrates the tumor immunosuppressive microenvironment, enhances the killing function of immune cells, and effectively inhibits tumor growth.”
BackgroundFunctional inorganic nanoparticles in cancer: Biomarker detection, imaging, and therapy
Li, M., Tang, Q., Wan, H., Zhu, G., Yin, D., Lei, L., & Li, S. (2024) · APL Materials · doi:10.1063/5.0231279 · Cited by 14
Metadata
- Authors
- Qing, S., Lyu, C., Zhu, L., Pan, C., Wang, S., Li, F., Wang, J., Yue, H., Gao, X., Jia, R., Wei, W., & Ma, G.
- Affiliations
- Chinese Academy of Sciences (CN)
- State Key Laboratory of Pathogen and Biosecurity Beijing Institute of Biotechnology No. 20 Dongda Street Beijing 100071 P. R. China
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Wei, Wei
- Ma, Guanghui
- ORCID
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2020-10-05
- Volume
- 32
- Issue
- 47
- Pages
- e2002085-e2002085
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W3090405704
- Cited by
- 309
- References
- 48
- Citations by year
- 2026: 31 · 2025: 72 · 2024: 75 · 2023: 56 · 2022: 42 · 2021: 31 · 2020: 1
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Materials (publishedVersion)
- PubMed (publishedVersion)
- Institute of Process Engineering, CAS Institutional Repository (submittedVersion)
- Funders
- National Natural Science Foundation of China (21821005)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- bacterial outer membrane vesicles, biomineralization, tumor microenvironment reprogramming, immunosuppression, M2 to M1 macrophage polarization, pH-responsive drug delivery, folic acid, photosensitizers, combination therapy, intravenous injection
- MeSH terms
- Extracellular Vesicles, Biomineralization, Bacterial Outer Membrane, Adjuvants, Immunologic, Immunotherapy, Macrophages, Safety, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.